Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2020-05-18 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Investor Presentation
Regulatory Filings
2020-05-18 English
Press Release
Regulatory Filings
2020-05-18 English
Financial Result Updates
Regulatory Filings
2020-05-18 English
Outcome of Board Meeting
Regulatory Filings
2020-05-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges announcing a conference call for investors and analysts to discuss the Q4 and full fiscal year 2020 financial and operating performance. It references the upcoming earnings announcement and provides details for the call, including dial-in numbers and participant instructions. There is no actual financial data or results presented in the document itself, only an invitation and notice of the conference call. This fits the definition of a Call Transcript (CT) only if it contained the full transcript, but here it is just an invitation. It is not an Earnings Release (ER) because it does not contain financial highlights or results, only a notice of the call where results will be discussed. The document is longer than 5,000 characters but does not contain substantive financial data or analysis. Therefore, the best classification is Regulatory Filings (RNS) as a general regulatory announcement about the conference call for earnings results.
2020-05-13 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about an upcoming Board Meeting scheduled to consider and approve the audited financial results for the quarter and financial year ended March 31, 2020. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed entities. The document does not contain any financial data or results itself, nor does it include detailed reports or presentations. It is essentially an announcement of a Board Meeting, not the meeting materials or results. Therefore, the appropriate classification is a Regulatory Filing (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2020-05-07 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.